Difference in prognostic value between sialyl Lewisa and sialyl Lewis(x) antigens in blood samples obtained from the drainage veins of the colorectal tumors

Cancer Letters

Volumn 159, Issue 2, 2000, Pages 159-168

  Nakagoe, Tohru ^a   Sawai, Terumitsu ^a   Tsuji, Takashi ^a   Jibiki, Masa Aki ^a   Ohbatake, Masayuki ^a   Nanashima, Atsushi ^a   Yamaguchi, Hiroyuki ^a   Kurosaki, Nobuko ^a   Yasutake, Toru ^a   Ayabe, Hiroyoshi ^a   Tagawa, Yutaka ^b  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

Author keywords

Colorectal cancer; Drainage vein; Sialyl Lewis(x); Sialyl Lewisa

Indexed keywords

CA 19-9 ANTIGEN;

ADULT; AGED; ANTIBODY TITER; ARTICLE; BLOOD GROUP LEWIS SYSTEM; BLOOD SAMPLING; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COLORECTAL TUMOR; FEMALE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROGNOSIS; VEIN; VENOUS BLOOD;

ADULT; AGED; AGED, 80 AND OVER; CA-19-9 ANTIGEN; COLORECTAL NEOPLASMS; COMPARATIVE STUDY; FEMALE; FOLLOW-UP STUDIES; HUMAN; MALE; MIDDLE AGE; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; OLIGOSACCHARIDES; PROGNOSIS; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 0034739713     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(00)00541-3     Document Type: Article

References (27)

1. Dabelsteen E. Cell surface carbohydrates as prognostic markers in human carcinomas. J. Pathol. 179:1996;358-369.
2. Arends J.W., Verstynen C., Bosman F.T., Hilgers J., Steplewski Z. Distribution of monoclonal antibody-defined monosialoganglioside in normal and cancerous human tissues: an immunoperoxidase study. Hybridoma. 2:1983;219-229.
3. 6) in normal and tumor tissues defined by its monoclonal antibody FH6. Cancer Res. 45:1985;3711-3717.
4. x antigens in primary colorectal carcinomas and lymph node and hepatic lesions. J. Gastroenterol. 29:1994;129-138.
5. x as a new tumor-associated antigen. Cancer Res. 44:1984;5279-5285.
6. Takada A., Ohmori K., Yoneda T., Tsuyuoka K., Hasegawa A., Kiso M., Kannagi R. Contribution of carbohydrate antigens sialyl Lewis A and sialyl Lewis X to adhesion of human cancer cells to vascular endothelium. Cancer Res. 53:(2):1993;354-361.
7. Magnani J.L. The tumor markers, sialyl Le(a) and sialyl Le(x) bind ELAM-1 (letter), Glycobiology. 1:(4):1991;318-320.
8. Iwai K., Ishikura H., Kaji M., Sugiura H., Ishizu A., Takahashi C., Kato H., Tanabe T., Yoshiki T. Importance of E-selectin (ELAM-1) and sialyl Lewis(a) in the adhesion of pancreatic carcinoma cells to activated endothelium. Int. J. Cancer. 54:(6):1993;972-977.
9. a as a new prognostic factor for patients with advanced colorectal carcinoma. Cancer. 75:1995;2051-2056.
10. x antigen in relation to survival of patients with colorectal carcinoma. Cancer. 72:1993;2323-2330.
11. x antigen correlates with poor survival in patients with colorectal carcinoma: clinicopathological and immunohistochemical study. Cancer Res. 53:1993;3632-3637.
12. Filella X., Molina R., Grau J.J., Pique J.M., Garcia-Valdecasas J.C., Astudillo E., Biete A., Bordas J.M., Novell A., Campo E., Ballesta A.M. Prognostic value of CA 19.9 levels in colorectal cancer. Ann. Surg. 216:1992;55-59.
13. Tabuchi Y., Deguchi H., Imanishi K., Saitoh Y. Comparison of carcinoembryonic antigen levels between portal and peripheral blood in patients with colorectal cancer. Correlation with histopathologic variables. Cancer. 59:1987;1283-1288.
14. Tabuchi Y., Deguchi H., Saitoh Y. Carcinoembryonic antigen and carbohydrate antigen 19-9 levels of peripheral and draining venous blood in colorectal cancer patients. Correlation with histopathologic and immunohistochemical variables. Cancer. 62:1988;1605-1613.
15. Del Villano B.C., Brennan S., Brock P., Bucher C., Liu V., McClure M., Rake B., Space S., Westrick B., Schoemaker H., Zurawski V.R. Jr. Radioimmunometric assay for a monoclonal antibody-defined tumor marker, CA 19-9. Clin. Chem. 29:1983;549-552.
16. Imura H., Endo J., Ohkura H., Ishii M., Ariyoshi Y., Abe O., Masamune O., Nishimoto Y., Fukushi Y., Orikasa S., Hakomori S.I., Kannnagi R. Initial basic and clinical evaluation of a solid-phase immunoradiometric assay for sialyl SSEA-1 antigen: 1 Evaluation of assay conditions and normal values. Jpn. J. Cancer Chemother. 14:1987;1315-1321.
17. Fleming I.D., Cooper J.S., Henson D.E., Hutter V.P., Kennedy B.J., Murphy G.P., O'Sullivan B., Sobin L.H., Yarbro J.W. Colon and Rectum. AJCC Cancer Staging Manual. 1997;83-90 Lippincott-Raven, New York.
18. Jass J.R., Sobin L.H. Large Intestine. World Health Organization International Histological Classification of Tumours. Histological typing of intestinal tumours. 1989;29-40 Springer-Verlag, New York.
19. Massey F.J. Jr. The Kolmogorov-Smirnov test for goodness of fit. J. Am. Stat. Assoc. 46:1951;68-78.
20. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observation. J. Am. Stat. Assoc. 16:1977;95-101.
21. Peto R., Pike M.C., Armitage P., Breslow N.E., Cox D.R., Howard S.V., Mantel N., McPherson K., Peto J., Smith P.G. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. Br. J. Cancer. 35:1977;1-27.
22. Cox D.R. Regression models and life tables. J. R. Stat. Soc. 34:1972;187-220.
23. Ueda T., Shimada E., Urakawa T. The clinicopathological features of serum CA19-9-positive colorectal cancers. Surg. Today. 24:1994;518-525.
24. Nakayama T., Watanabe M., Teramoto T., Kitajima M. CA19-9 as a predictor of recurrence in patients with colorectal cancer. J. Surg. Oncol. 66:1997;238-243.
25. x determinant on myeloid and tumor cells. Science. 250:1990;1132-1134.
26. x, Science. 250:1990;1130-1132.
27. a. Biochem. Biophys. Res. Commun. 184:1992;1048-1055.